Balchem (BCPC) 주식
상장 기업. 9월 2026 기준 Balchem의 주가, 사업 개요, 알아두어야 할 핵심 정보를 정리했습니다.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
6개월 성장 성과
주가 성과 요약
애널리스트 평가
Analysts recommend buying Balchem Corp's stock, anticipating an increase in its value.
재무 건전성
Balchem Corp shows strong revenue and cash generation, indicating solid financial performance overall.
배당
Balchem Corp offers a low dividend yield of 0.58%, making it less attractive for income-focused investors. If you invested $1000 you would be paid $5.80 a year in dividends (based on the last 12 months).
왜 Nemo와 함께 투자해야 할까요?
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
